Trials / Conditions / Allosensitization
Allosensitization
5 registered clinical trials studyying Allosensitization.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Isatuximab in Lung Transplant Recipients NCT05862766 | NYU Langone Health | EARLY_Phase 1 |
| Completed | Daratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation NCT04610320 | Ronald Witteles | Phase 1 |
| Withdrawn | Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantati NCT04088903 | Ronald Witteles | Phase 1 |
| Completed | Desensitization in Kidney Allograft Using Daratumumab NCT04204980 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Terminated | Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisa NCT03689075 | Imperial College Healthcare NHS Trust | Phase 4 |